On the other hand, the anti-inflammatory properties of IL-1Ra may suppress anti-tumor immunogenic responses, as it can inhibit production of effector cytokines in CD4 T cells [17] and antigen-specific T cell responses in mice that have been immunized with tumor neoantigens [18]. The gene discussed is CD4; the disease is neoplasm.